Maximilian Hammer Selected Research

Neuromuscular Blocking Agents

1/2021	Optimal Sedation in Patients Who Receive Neuromuscular Blocking Agent Infusions for Treatment of Acute Respiratory Distress Syndrome-A Retrospective Cohort Study From a New England Health Care Network.
10/2020	Succinylcholine and postoperative pulmonary complications: a retrospective cohort study using registry data from two hospital networks.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maximilian Hammer Research Topics

Disease

1	Retinal Diseases 01/2022
1	Anemia 11/2021
1	Hyperglycemia 11/2021
1	Hypotension (Low Blood Pressure) 11/2021
1	Nausea 01/2021
1	Pain (Aches) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Vision Disorders (Hemeralopia) 01/2021
1	Vomiting 01/2021
1	Paralysis (Palsy) 10/2020
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2020
1	Delirium 01/2020

Drug/Important Bio-Agent (IBA)

2	Neuromuscular Blocking AgentsIBA 01/2021 - 10/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Hemoglobins (Hemoglobin)IBA 11/2021
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 11/2021
1	Succinylcholine (Suxamethonium Chloride)FDA LinkGeneric 10/2020
1	suvorexantIBA 01/2020
1	Orexin Receptor AntagonistsIBA 01/2020

Therapy/Procedure

2	Length of Stay 11/2021 - 01/2021
1	Therapeutics 01/2022
1	Analgesia 01/2021
1	Conduction Anesthesia (Regional Anesthesia) 01/2021
1	Intraocular Lenses (Intraocular Lens) 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021